Verification of Safety and Efficacy of Enoki Mushroom Extract Powder Foods in Male Menopausal Symptoms

Clinical research on the beneficial effect of Enoki Mushroom Extract Powder Food on male menopausal symptoms

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs041220142

Enrollment

Registered

2023-02-14

Start date

2023-06-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal male (healthy male)

Interventions

To evaluate menopausal symptoms improvement effect of powdered enoki mushroom extract food in men with menopausal symptoms.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1) Men over 40 years of age. 2) AMS score of 27 or more, but less than 50

Exclusion criteria

Exclusion criteria: 1) Those undergoing treatment for male menopause 2)Within 2 months after completion of treatment for male menopause 3) Patients suffering from lifestyle-related diseases. 4) Those who are taking medicines, newly designated quasi-drugs, herbal medicines, health foods, and supplements related to the promotion of testosterone secretion. 5) Persons who are participating or will participate in other clinical research studies at the time this study is initiated 6) PSA level of 4.0ng/mL or higher 7) Other persons deemed inappropriate by the principal investigator

Design outcomes

Primary

Measure	Time frame
Heinemann Aging males symptoms score	—

Secondary

Measure	Time frame
Beck Depression Inventory(BDI2), activity scale for the elderly(ASE), Nocturia Quality-of-Life Questionnaire(N-QOL) , Grip strength test and Skeletal muscle mass test, Total and free testosterone, Pittsburgh Sleep Quality Index( PSQI)	—

Contacts

Public ContactShizuo Yamada

Center for Pharma-Food Research (CPFR), Graduate School of Pharmaceutical Sciences, University of Shizuoka

yamada@u-shizuoka-ken.ac.jp+81-54-264-5625

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026